---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-044746"
form_type: "8-K"
ticker: null
cik: "0001733413"
company_name: "TFF Pharmaceuticals, Inc."
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T16:20:59.296584+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TFF Pharmaceuticals enters ATM equity offering agreement with H.C. Wainwright

## Summary
- Agreement allows sale of common stock at Company's discretion under effective S-3 registration statement.
- Agent commission set at 3% of gross proceeds; Company reimburses up to $50,000 in expenses.
- Sales may be made through at-the-market offerings, including negotiated and block transactions.
- No minimum or maximum offering amount specified; proceeds for general corporate purposes.

## SEC filing metadata
- accession: 0001213900-24-044746
- form_type: 8-K
- cik: 0001733413
- company_name: TFF Pharmaceuticals, Inc.
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733413/000121390024044746/0001213900-24-044746-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733413/000121390024044746/ea0206421-8k_tffpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-044746
- JSON: https://secwatch.observer/filing/0001213900-24-044746.json
- Plain text: https://secwatch.observer/filing/0001213900-24-044746.txt

## Key facts
- Material Agreements
  TFF Pharmaceuticals, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2024-05-17).
  - Action: entry
  - Agreement: atm program
  - Counterparty: H.C. Wainwright & Co., LLC
  - Effective: 2024-05-17
  source text: On May 17, 2024, TFF Pharmaceuticals, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC (“Agent”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its $0.001 par value common stock (“Common Stock”), through the Agent as its sales agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733413/000121390024044746/0001213900-24-044746-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.